Anvisa ends the process that called for emergency use of the Covaxin vaccine – Prime Time Zone


The decision, taken unanimously, is released a day after the manufacturer of the Indian immunizing agent broke the contract with Necessidade, which intermediated the negotiation with the Ministry of Health

EFE / Rajat Gupta / ArchiveEmergency use of Covaxin vaccine will no longer be evaluated

The National Health Surveillance Agency (Anvisa) The process that requested the emergency use of the vaccine ended this Saturday, 24th, in a unanimous decision. Covaxin in Brazil. The board of the collegiate met a day after Bharat Biotech, maker of the Indian immunizing agent against Covid-19, terminated its contract with Need Medicines and denying the authenticity of the documents that the intermediary company sent to the Ministry of Health. In the statement, Bharat said that Covaxin was offered to Brazil at the price of US$ 15 per dose and emphasized that it did not receive any advance or provide vaccines to the country .

The Ministry of Health suspended Covaxin’s contract after negotiations stopped at CPI to Covid-19. the federal deputy Luis Miranda he denounced that the contract signed by the folder agreed a price higher than that practiced and that his brother Luís Ricardo Miranda, who is a Health server, had reported strong pressure to approve the contract for the purchase of the Indian vaccine. The commission’s work will resume on August 3rd and the owner of Necessidade, Francisco Maximiano, known as Max, should be heard in the first week of testimonies after the end of the parliamentary recess.